Global Artemisinic Acid Market Size study, by Type (Antimalarial Injections, Antimalarial Tablets) and Regional Forecasts 2022-2032
Global Artemisinic Acid Market is valued approximately at USD 0.72 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.24% over the forecast period 2024-2032. Artemisinic acid, a vital precursor to artemisinin, lies at the heart of one of the most effective antimalarial therapies known to modern medicine. Derived either from the Artemisia annua plant or biosynthetically via engineered yeast strains, artemisinic acid serves as a strategic molecule in combating Plasmodium falciparum—the deadliest strain of malaria. The global market for artemisinic acid has evolved into a mission-critical component of global healthcare strategies in malaria-endemic regions, bridging the gap between natural extraction constraints and scalable pharmaceutical synthesis.
As global health authorities intensify their eradication efforts against malaria, demand for artemisinin-based combination therapies (ACTs) continues to surge. This demand surge has made artemisinic acid indispensable to the supply chain. In tandem with this trend, biotechnology breakthroughs in semi-synthetic production methods have dramatically enhanced yield, cost efficiency, and manufacturing scalability. Pharmaceutical manufacturers and public-private partnerships alike are capitalizing on these advancements to meet the growing treatment needs, particularly in Africa and Southeast Asia. Nevertheless, production remains tethered to challenges such as fluctuating agricultural yields, limited supplier diversification, and quality control complexities—posing critical hurdles for long-term market stability.
Moreover, market participants are navigating a dynamic pricing environment driven by the dual forces of donor funding and national procurement programs. While the semi-synthetic route offers promising consistency and cost control, its integration into large-scale manufacturing remains resource-intensive. Companies are actively exploring next-generation synthesis methods to reduce environmental impact and regulatory bottlenecks, aligning with broader ESG (Environmental, Social, and Governance) goals. As innovations continue to push the technological frontier, the market is also witnessing an uptick in interest from generic drug manufacturers aiming to enter the antimalarial space via API partnerships centered on artemisinic acid.
Regionally, the market reveals a layered global footprint. Sub-Saharan Africa remains the primary demand center due to its high malaria burden, supported by international aid and governmental health policies focused on ACT procurement. Meanwhile, Asia Pacific—particularly countries like India, Vietnam, and Indonesia—exhibits significant manufacturing capacity and growing domestic demand for artemisinin-derived treatments. North America and Europe, while representing modest consumption, play pivotal roles in research, funding, and strategic production partnerships. In Latin America and the Middle East, ongoing malaria containment programs are gradually expanding the scope for artemisinic acid applications, particularly as part of preventative strategies in vulnerable populations.
Major market player included in this report are:
By Type
North America
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
As global health authorities intensify their eradication efforts against malaria, demand for artemisinin-based combination therapies (ACTs) continues to surge. This demand surge has made artemisinic acid indispensable to the supply chain. In tandem with this trend, biotechnology breakthroughs in semi-synthetic production methods have dramatically enhanced yield, cost efficiency, and manufacturing scalability. Pharmaceutical manufacturers and public-private partnerships alike are capitalizing on these advancements to meet the growing treatment needs, particularly in Africa and Southeast Asia. Nevertheless, production remains tethered to challenges such as fluctuating agricultural yields, limited supplier diversification, and quality control complexities—posing critical hurdles for long-term market stability.
Moreover, market participants are navigating a dynamic pricing environment driven by the dual forces of donor funding and national procurement programs. While the semi-synthetic route offers promising consistency and cost control, its integration into large-scale manufacturing remains resource-intensive. Companies are actively exploring next-generation synthesis methods to reduce environmental impact and regulatory bottlenecks, aligning with broader ESG (Environmental, Social, and Governance) goals. As innovations continue to push the technological frontier, the market is also witnessing an uptick in interest from generic drug manufacturers aiming to enter the antimalarial space via API partnerships centered on artemisinic acid.
Regionally, the market reveals a layered global footprint. Sub-Saharan Africa remains the primary demand center due to its high malaria burden, supported by international aid and governmental health policies focused on ACT procurement. Meanwhile, Asia Pacific—particularly countries like India, Vietnam, and Indonesia—exhibits significant manufacturing capacity and growing domestic demand for artemisinin-derived treatments. North America and Europe, while representing modest consumption, play pivotal roles in research, funding, and strategic production partnerships. In Latin America and the Middle East, ongoing malaria containment programs are gradually expanding the scope for artemisinic acid applications, particularly as part of preventative strategies in vulnerable populations.
Major market player included in this report are:
- Sanofi S.A.
- Ipca Laboratories Ltd.
- Guilin Pharmaceutical Co., Ltd.
- Cipla Limited
- Calyx Chemicals & Pharmaceuticals Ltd.
- Novartis AG
- Zhuhai Rundu Pharmaceutical Co., Ltd.
- KPC Pharmaceuticals, Inc.
- Zydus Lifesciences Ltd.
- Mediplantex
- Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
- BrightGene Bio-Medical Technology Co., Ltd.
- Kanion Pharmaceutical Co., Ltd.
- Bharat Pharmaceuticals
- Chongqing Holley Pharmaceutical Co., Ltd.
By Type
- Antimalarial Injections
- Antimalarial Tablets
North America
- U.S.
- Canada
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
- Sanofi S.A.
- Ipca Laboratories Ltd.
- Guilin Pharmaceutical Co., Ltd.
- Cipla Limited
- Calyx Chemicals & Pharmaceuticals Ltd.
- Novartis AG
- Zhuhai Rundu Pharmaceutical Co., Ltd.
- KPC Pharmaceuticals, Inc.
- Zydus Lifesciences Ltd.
- Mediplantex
- Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
- BrightGene Bio-Medical Technology Co., Ltd.
- Kanion Pharmaceutical Co., Ltd.
- Bharat Pharmaceuticals
- Chongqing Holley Pharmaceutical Co., Ltd.
CHAPTER 1. GLOBAL ARTEMISINIC ACID MARKET EXECUTIVE SUMMARY
1.1. Global Artemisinic Acid Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. –
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL ARTEMISINIC ACID MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL ARTEMISINIC ACID MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Escalating demand for artemisinin-based combination therapies
3.1.2. Biotechnological advances in semi-synthetic production
3.1.3. Strengthening public-private funding initiatives
3.2. Market Challenges
3.2.1. Agricultural yield volatility of Artemisia annua
3.2.2. Quality control and supplier concentration risks
3.3. Market Opportunities
3.3.1. Next-generation, eco-efficient synthesis methods
3.3.2. Expansion in malaria-endemic African and Southeast Asian markets
3.3.3. Partnerships for generic API supply
CHAPTER 4. GLOBAL ARTEMISINIC ACID MARKET INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Forces
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ARTEMISINIC ACID MARKET SIZE & FORECASTS BY TYPE (2022–2032)
5.1. Segment Dashboard
5.2. Global Artemisinic Acid Market: {Type} Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Antimalarial Injections
5.2.2. Antimalarial Tablets
CHAPTER 6. GLOBAL ARTEMISINIC ACID MARKET SIZE & FORECASTS BY REGION (2022–2032)
6.1. North America Artemisinic Acid Market
6.1.1. U.S. Market
6.1.2. Canada Market
6.2. Europe Artemisinic Acid Market
6.2.1. UK Market
6.2.2. Germany Market
6.2.3. France Market
6.2.4. Spain Market
6.2.5. Italy Market
6.2.6. Rest of Europe Market
6.3. Asia Pacific Artemisinic Acid Market
6.3.1. China Market
6.3.2. India Market
6.3.3. Japan Market
6.3.4. Australia Market
6.3.5. South Korea Market
6.3.6. Rest of Asia Pacific Market
6.4. Latin America Artemisinic Acid Market
6.4.1. Brazil Market
6.4.2. Mexico Market
6.4.3. Rest of Latin America Market
6.5. Middle East & Africa Artemisinic Acid Market
6.5.1. Saudi Arabia Market
6.5.2. South Africa Market
6.5.3. Rest of Middle East & Africa Market
CHAPTER 7. COMPETITIVE INTELLIGENCE
7.1. Key Company SWOT Analysis
7.1.1. Sanofi S.A.
7.1.2. Ipca Laboratories Ltd.
7.1.3. Guilin Pharmaceutical Co., Ltd.
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Sanofi S.A.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Ipca Laboratories Ltd.
7.3.3. Guilin Pharmaceutical Co., Ltd.
7.3.4. Cipla Limited
7.3.5. Calyx Chemicals & Pharmaceuticals Ltd.
7.3.6. Novartis AG
7.3.7. Zhuhai Rundu Pharmaceutical Co., Ltd.
7.3.8. KPC Pharmaceuticals, Inc.
7.3.9. Zydus Lifesciences Ltd.
7.3.10. Mediplantex
7.3.11. Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
7.3.12. BrightGene Bio-Medical Technology Co., Ltd.
7.3.13. Kanion Pharmaceutical Co., Ltd.
7.3.14. Bharat Pharmaceuticals
7.3.15. Chongqing Holley Pharmaceutical Co., Ltd.
CHAPTER 8. RESEARCH PROCESS
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
1.1. Global Artemisinic Acid Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. –
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL ARTEMISINIC ACID MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL ARTEMISINIC ACID MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Escalating demand for artemisinin-based combination therapies
3.1.2. Biotechnological advances in semi-synthetic production
3.1.3. Strengthening public-private funding initiatives
3.2. Market Challenges
3.2.1. Agricultural yield volatility of Artemisia annua
3.2.2. Quality control and supplier concentration risks
3.3. Market Opportunities
3.3.1. Next-generation, eco-efficient synthesis methods
3.3.2. Expansion in malaria-endemic African and Southeast Asian markets
3.3.3. Partnerships for generic API supply
CHAPTER 4. GLOBAL ARTEMISINIC ACID MARKET INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Forces
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ARTEMISINIC ACID MARKET SIZE & FORECASTS BY TYPE (2022–2032)
5.1. Segment Dashboard
5.2. Global Artemisinic Acid Market: {Type} Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Antimalarial Injections
5.2.2. Antimalarial Tablets
CHAPTER 6. GLOBAL ARTEMISINIC ACID MARKET SIZE & FORECASTS BY REGION (2022–2032)
6.1. North America Artemisinic Acid Market
6.1.1. U.S. Market
6.1.2. Canada Market
6.2. Europe Artemisinic Acid Market
6.2.1. UK Market
6.2.2. Germany Market
6.2.3. France Market
6.2.4. Spain Market
6.2.5. Italy Market
6.2.6. Rest of Europe Market
6.3. Asia Pacific Artemisinic Acid Market
6.3.1. China Market
6.3.2. India Market
6.3.3. Japan Market
6.3.4. Australia Market
6.3.5. South Korea Market
6.3.6. Rest of Asia Pacific Market
6.4. Latin America Artemisinic Acid Market
6.4.1. Brazil Market
6.4.2. Mexico Market
6.4.3. Rest of Latin America Market
6.5. Middle East & Africa Artemisinic Acid Market
6.5.1. Saudi Arabia Market
6.5.2. South Africa Market
6.5.3. Rest of Middle East & Africa Market
CHAPTER 7. COMPETITIVE INTELLIGENCE
7.1. Key Company SWOT Analysis
7.1.1. Sanofi S.A.
7.1.2. Ipca Laboratories Ltd.
7.1.3. Guilin Pharmaceutical Co., Ltd.
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Sanofi S.A.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Ipca Laboratories Ltd.
7.3.3. Guilin Pharmaceutical Co., Ltd.
7.3.4. Cipla Limited
7.3.5. Calyx Chemicals & Pharmaceuticals Ltd.
7.3.6. Novartis AG
7.3.7. Zhuhai Rundu Pharmaceutical Co., Ltd.
7.3.8. KPC Pharmaceuticals, Inc.
7.3.9. Zydus Lifesciences Ltd.
7.3.10. Mediplantex
7.3.11. Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
7.3.12. BrightGene Bio-Medical Technology Co., Ltd.
7.3.13. Kanion Pharmaceutical Co., Ltd.
7.3.14. Bharat Pharmaceuticals
7.3.15. Chongqing Holley Pharmaceutical Co., Ltd.
CHAPTER 8. RESEARCH PROCESS
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
LIST OF TABLES
TABLE 1. Global Artemisinic Acid market, report scope
TABLE 2. Global Artemisinic Acid market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Artemisinic Acid market estimates & forecasts by Type 2022–2032 (USD Million)
TABLE 4. Global Artemisinic Acid market by segment, estimates & forecasts, 2022–2032 (USD Million)
TABLE 5. North America Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 6. U.S. Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 7. Canada Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 8. Europe Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 9. UK Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 10. Germany Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 11. France Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 12. Spain Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 13. Italy Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 14. Asia Pacific Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 15. China Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 16. India Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 17. Japan Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 18. Latin America Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 19. Brazil Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 20. Middle East & Africa Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 1. Global Artemisinic Acid market, report scope
TABLE 2. Global Artemisinic Acid market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Artemisinic Acid market estimates & forecasts by Type 2022–2032 (USD Million)
TABLE 4. Global Artemisinic Acid market by segment, estimates & forecasts, 2022–2032 (USD Million)
TABLE 5. North America Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 6. U.S. Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 7. Canada Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 8. Europe Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 9. UK Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 10. Germany Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 11. France Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 12. Spain Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 13. Italy Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 14. Asia Pacific Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 15. China Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 16. India Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 17. Japan Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 18. Latin America Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 19. Brazil Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
TABLE 20. Middle East & Africa Artemisinic Acid market estimates & forecasts, 2022–2032 (USD Million)
LIST OF FIGURES
FIG 1. Global Artemisinic Acid market, research methodology
FIG 2. Global Artemisinic Acid market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Artemisinic Acid market, key trends 2023
FIG 5. Global Artemisinic Acid market, growth prospects 2022–2032
FIG 6. Global Artemisinic Acid market, Porter’s Five Forces model
FIG 7. Global Artemisinic Acid market, PESTEL analysis
FIG 8. Global Artemisinic Acid market, value chain analysis
FIG 9. Global Artemisinic Acid market by segment, 2022 & 2032 (USD Million)
FIG 10. Global Artemisinic Acid market by segment, 2022 & 2032 (USD Million)
FIG 11. Global Artemisinic Acid market by segment, 2022 & 2032 (USD Million)
FIG 12. Global Artemisinic Acid market by segment, 2022 & 2032 (USD Million)
FIG 13. Global Artemisinic Acid market by segment, 2022 & 2032 (USD Million)
FIG 14. Global Artemisinic Acid market, regional snapshot 2022 & 2032
FIG 15. North America Artemisinic Acid market 2022 & 2032 (USD Million)
FIG 16. Europe Artemisinic Acid market 2022 & 2032 (USD Million)
FIG 17. Asia-Pacific Artemisinic Acid market 2022 & 2032 (USD Million)
FIG 18. Latin America Artemisinic Acid market 2022 & 2032 (USD Million)
FIG 19. Middle East & Africa Artemisinic Acid market 2022 & 2032 (USD Million)
FIG 20. Global Artemisinic Acid market, company market share analysis (2023)
FIG 1. Global Artemisinic Acid market, research methodology
FIG 2. Global Artemisinic Acid market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Artemisinic Acid market, key trends 2023
FIG 5. Global Artemisinic Acid market, growth prospects 2022–2032
FIG 6. Global Artemisinic Acid market, Porter’s Five Forces model
FIG 7. Global Artemisinic Acid market, PESTEL analysis
FIG 8. Global Artemisinic Acid market, value chain analysis
FIG 9. Global Artemisinic Acid market by segment, 2022 & 2032 (USD Million)
FIG 10. Global Artemisinic Acid market by segment, 2022 & 2032 (USD Million)
FIG 11. Global Artemisinic Acid market by segment, 2022 & 2032 (USD Million)
FIG 12. Global Artemisinic Acid market by segment, 2022 & 2032 (USD Million)
FIG 13. Global Artemisinic Acid market by segment, 2022 & 2032 (USD Million)
FIG 14. Global Artemisinic Acid market, regional snapshot 2022 & 2032
FIG 15. North America Artemisinic Acid market 2022 & 2032 (USD Million)
FIG 16. Europe Artemisinic Acid market 2022 & 2032 (USD Million)
FIG 17. Asia-Pacific Artemisinic Acid market 2022 & 2032 (USD Million)
FIG 18. Latin America Artemisinic Acid market 2022 & 2032 (USD Million)
FIG 19. Middle East & Africa Artemisinic Acid market 2022 & 2032 (USD Million)
FIG 20. Global Artemisinic Acid market, company market share analysis (2023)
